LON:DNL - Diurnal Group Stock Price, News, & Analysis

GBX 29.50
0.00 (0.00 %)
(As of 06/19/2019 01:06 AM ET)
Today's Range
Now: GBX 29.50
50-Day Range
MA: GBX 30.45
52-Week Range
Now: GBX 29.50
Volume855,080 shs
Average Volume7,428 shs
Market Capitalization£18.21 million
P/E RatioN/A
Dividend YieldN/A
Diurnal Group plc operates as a specialty pharma company. The company develops hormone therapeutics for the treatment of chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism, and hypothyroidism. Its product pipeline includes Infacort for use in children suffering from adrenal insufficiency; and Chronocort, which completed Phase III clinical trials targeting congenital adrenal hyperplasia in adult patients, as well as adrenal insufficiency. Read More…

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic



Sales & Book Value

Annual Sales£259,000.00
Cash FlowGBX 12.24 per share
Book ValueGBX 14.90 per share



Market Cap£18.21 million
Next Earnings DateN/A
OptionableNot Optionable

Receive DNL News and Ratings via Email

Sign-up to receive the latest news and ratings for DNL and its competitors with MarketBeat's FREE daily newsletter.

Diurnal Group (LON:DNL) Frequently Asked Questions

What is Diurnal Group's stock symbol?

Diurnal Group trades on the London Stock Exchange (LON) under the ticker symbol "DNL."

How were Diurnal Group's earnings last quarter?

Diurnal Group PLC (LON:DNL) announced its quarterly earnings data on Monday, March, 12th. The company reported ($12.70) earnings per share (EPS) for the quarter. View Diurnal Group's Earnings History.

Has Diurnal Group been receiving favorable news coverage?

News coverage about DNL stock has trended somewhat positive on Wednesday, InfoTrie reports. The research firm rates the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Diurnal Group earned a media sentiment score of 1.5 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for Diurnal Group.

Who are some of Diurnal Group's key competitors?

What other stocks do shareholders of Diurnal Group own?

Who are Diurnal Group's key executives?

Diurnal Group's management team includes the folowing people:
  • Dr. Martin Whitaker B.Sc., BSc, Ph.D., CEO & Exec. Director
  • Mr. Richard Edward Bungay BSc, ACA, CFO,Director & Company Sec. (Age 50)
  • Prof. Richard Ross, Chief Scientific Officer & Exec. Director
  • Mr. Michael Withe, Commercial Director
  • Mr. John Porter, Medical Director

How do I buy shares of Diurnal Group?

Shares of DNL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Diurnal Group's stock price today?

One share of DNL stock can currently be purchased for approximately GBX 29.50.

How big of a company is Diurnal Group?

Diurnal Group has a market capitalization of £18.21 million and generates £259,000.00 in revenue each year. Diurnal Group employs 23 workers across the globe.View Additional Information About Diurnal Group.

What is Diurnal Group's official website?

The official website for Diurnal Group is http://www.diurnal.co.uk/.

How can I contact Diurnal Group?

Diurnal Group's mailing address is Heath Park, CARDIFF, CF14 4UJ, United Kingdom. The company can be reached via phone at +44-29-20682069.

MarketBeat Community Rating for Diurnal Group (LON DNL)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  156 (Vote Outperform)
Underperform Votes:  117 (Vote Underperform)
Total Votes:  273
MarketBeat's community ratings are surveys of what our community members think about Diurnal Group and other stocks. Vote "Outperform" if you believe DNL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DNL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/19/2019 by MarketBeat.com Staff

Featured Article: What is a Swap?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel